Effect of early administration of tolvaptan on pleural effusion post-hepatectomy
Not Applicable
- Conditions
- Cases of hepatectomy
- Registration Number
- JPRN-UMIN000051266
- Lead Sponsor
- Shiga Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 136
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with hyperkalemia (>5.5 mEq/L), diabetes insipidus, preoperative blood sodium level of <125 mEq/L or >150 mEq/L, serum creatinine level of >2 mg/dL, difficulties in communication due to psychiatric disorders, patients on dialysis, and those on tolvaptan orally administered before hepatectomy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pleural effusion volume on post-hepatectomy day 5
- Secondary Outcome Measures
Name Time Method